Seres Therapeutics
MCRB
MCRB
32 hedge funds and large institutions have $40.9M invested in Seres Therapeutics in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 7 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
1.88% less ownership
Funds ownership: 26.17% → 24.28% (-1.9%)
3% less funds holding
Funds holding: 33 → 32 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
Holders
32
Holding in Top 10
1
Calls
$17.4M
Puts
$2.6M
Top Buyers
| 1 | +$658K | |
| 2 | +$594K | |
| 3 | +$557K | |
| 4 |
JGC
J. Goldman & Co
New York
|
+$519K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$381K |
Top Sellers
| 1 | -$5.13M | |
| 2 | -$249K | |
| 3 | -$232K | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$155K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$139K |
